InterMune Inc. (Nasdaq: ITMN) retained the services of Centerview Partners and Goldman Sachs to explore strategic options including a possible sale of the company. The stock price leaped $6.57 to close at $52.06.
InterMune explores options
August 13, 2014 at 18:10 PM EDT